FC
Farallon Capital Management, L.L.C. cut $270M of TNGX stock
Farallon Capital Management, L.L.C. cut $270M of Tango Therapeutics, Inc. (TNGX) stock in the quarter ending Sep 30, 2026, per a 13F filed Nov 16, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- Nov 16, 2026
- Quarter end
- Sep 30, 2026
- Source
- SEC Form 13F